Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients - Concepedia

Concepedia

Publication | Closed Access

Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients

10

Citations

26

References

2019

Year

Marta Santaliestra, Ana Garrido, Maite Carricondo, Elena Bussaglia, Marta Pratcorona, María Laura Blanco, Ignasi Gich, Montserrat Hoyos, Albert Esquirol, Irene García‐Cadenas,

European Journal Of Haematology

Abstract

Further studies are needed to assess whether BM WT1 levels could be useful to predict the survival of patients with myeloid neoplasms treated with 5-azacytidine.

References

	Year	Citations

Page 1